Mid-term Results of Tissue Engineered Valvular Grafts for Pulmonary Valve Replacement in Pediatric Patients and Young Adults

CEBOTARI, S.; TUDORACHE, I.; CHEPTANARU, E.; BARNACIUC, S.; CAZACU, A.; MALIGA, O.; REPIN, O.; MANIUC, L.; BREYMANN, T.; SARIKOUCH, S.; BOETHIG, D.; GOERLER, A.; HAVERICH, A.; CIUBOTARU, A.

Home
→
Facultatea Calculatoare, Informatică şi Microelectronică
→
Conferinţe
→
Conferinţa ICNBME - International Conference on Nanotechnologies and Biomedical Engineering
→
2011
→
View Item

Mid-term Results of Tissue Engineered Valvular Grafts for Pulmonary Valve Replacement in Pediatric Patients and Young Adults

CEBOTARI, S.; TUDORACHE, I.; CHEPTANARU, E.; BARNACIUC, S.; CAZACU, A.; MALIGA, O.; REPIN, O.; MANIUC, L.; BREYMANN, T.; SARIKOUCH, S.; BOETHIG, D.; GOERLER, A.; HAVERICH, A.; CIUBOTARU, A.

URI: http://repository.utm.md/handle/5014/5406

Date: 2011

Abstract:

Graft degeneration is a major cause of reoperation in young patients after pulmonary valve replacement. Glutaraldehyde fixed or cryopreserved grafts lack the potential to growth. Here we present the mid-term results of implantation of tissue engineered pulmonary homografts (TEPH) compared to glutaraldehyde-fixed bovine jugular vein (BJV) and cryopreserved homografts (CH).